CorMedix (CRMD) Cash & Current Investments (2010 - 2025)

CorMedix has disclosed Cash & Current Investments across 16 years of filings, most recently posting $155.2 million for Q4 2025.

• Cash & Current Investments for Q4 2025 came in at $155.2 million, up 200.27% year-over-year; the trailing twelve-month figure through Dec 2025 was $155.2 million (up 200.27% YoY), and the FY2025 annual result was $155.2 million, up 200.27% from the prior year.
• Cash & Current Investments came in at $155.2 million for Q4 2025 at CorMedix, up from $55.7 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $190.7 million in Q2 2025 to a low of $19.8 million in Q2 2023.
• The 5-year median for Cash & Current Investments is $55.7 million (2023), against an average of $66.3 million.
• Across the five-year window, Cash & Current Investments surged 342.79% in 2021 and sank 68.91% in 2022, its largest moves.
• CorMedix's Cash & Current Investments stood at $53.4 million in 2021, then fell by 19.04% to $43.3 million in 2022, then climbed by 1.03% to $43.7 million in 2023, then advanced by 18.22% to $51.7 million in 2024, then jumped by 200.27% to $155.2 million in 2025.
• The last three Cash & Current Investments figures came in at $155.2 million (Q4 2025), $55.7 million (Q3 2025), and $190.7 million (Q2 2025), per Business Quant data.